Stable Receptor-Associated Protein (RAP/LRPAP1) is an engineered recombinant protein used as an antagonist of LRP1 (low-density lipoprotein receptor-related protein 1). This stable RAP construct contains mutations that increase resistance to pH- and heat-induced denaturation, allowing high-affinity binding to LRP1 and inhibition of LRP1 function in vitro and in vivo.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.